Open Label Continuation Study in Moderate to Severe Psoriasis
A Phase 3, Multi-center, Open-label Continuation Study in Moderate to Severe Plaque Psoriasis in Subjects Who Completed a Preceding Psoriasis Study With ABT-874
2 other identifiers
interventional
2,301
14 countries
152
Brief Summary
The purpose of this study is to evaluate long term safety, efficacy and tolerability of ABT-874 in adults with moderate to severe psoriasis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Feb 2008
Typical duration for phase_3
152 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 22, 2008
CompletedFirst Posted
Study publicly available on registry
February 29, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedJanuary 30, 2013
January 1, 2013
3.7 years
February 22, 2008
January 28, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Proportion of subjects achieving PGA "clear" (0) or "minimal" (1) scores by visit.
Visit (12 weeks)
Proportion of subjects achieving a > PASI 50 clinical response that is defined as a reduction on PASI scores by at least 50% relative to Baseline, by visit.
Visit (12 weeks)
Proportion of subjects achieving a > PASI 75 clinical response that is defined as a reduction on PASI scores by at least 50% relative to Baseline, by visit.
Visit (12 weeks)
AEs, serious adverse events (SAEs), laboratory data, ADA and vital signs will be assessed throughout the study
Visit (12 weeks)
Study Arms (1)
1
EXPERIMENTALInterventions
100mg ABT-874 administered SQ every 4 wks for approximately 204 weeks
Eligibility Criteria
You may qualify if:
- Having participated in a preceding ABT-874 clinical trial for ABT-874
- Subject has a clinical diagnosis of moderate to severe plaque psoriasis
You may not qualify if:
- Subjects who prematurely discontinued in any preceding psoriasis study with ABT-874 other than protocol-required discontinuation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (152)
Site Reference ID/Investigator# 7496
Birmingham, Alabama, 35205, United States
Site Reference ID/Investigator# 8438
Birmingham, Alabama, 35233, United States
Site Reference ID/Investigator# 7522
Huntsville, Alabama, 35801, United States
Site Reference ID/Investigator# 7774
Scottsdale, Arizona, 85251, United States
Site Reference ID/Investigator# 7435
Tucson, Arizona, 85710, United States
Site Reference ID/Investigator# 7933
Little Rock, Arkansas, 72204, United States
Site Reference ID/Investigator# 7234
Bakersfield, California, 93309, United States
Site Reference ID/Investigator# 8249
Fresno, California, 93720, United States
Site Reference ID/Investigator# 7332
Irvine, California, 92697, United States
Site Reference ID/Investigator# 7239
Los Angeles, California, 90045, United States
Site Reference ID/Investigator# 8390
Oceanside, California, 92056, United States
Site Reference ID/Investigator# 7503
San Diego, California, 92103, United States
Site Reference ID/Investigator# 7520
San Diego, California, 92117, United States
Site Reference ID/Investigator# 7010
San Diego, California, 92123, United States
Site Reference ID/Investigator# 10962
San Francisco, California, 94118, United States
Site Reference ID/Investigator# 7334
Santa Monica, California, 90404, United States
Site Reference ID/Investigator# 7793
Vallejo, California, 94589, United States
Site Reference ID/Investigator# 7929
Denver, Colorado, 80209, United States
Site Reference ID/Investigator# 7436
Longmont, Colorado, 80501, United States
Site Reference ID/Investigator# 7521
New Haven, Connecticut, 06511, United States
Site Reference ID/Investigator# 7653
Doral, Florida, 33166-6665, United States
Site Reference ID/Investigator# 8341
Jacksonville, Florida, 32204, United States
Site Reference ID/Investigator# 7716
Miami, Florida, 33136, United States
Site Reference ID/Investigator# 7657
Miami, Florida, 33144, United States
Site Reference ID/Investigator# 10841
South Miami, Florida, 33143, United States
Site Reference ID/Investigator# 7893
West Palm Beach, Florida, 33409-3509, United States
Site Reference ID/Investigator# 7331
Alpharetta, Georgia, 30022, United States
Site Reference ID/Investigator# 9743
Atlanta, Georgia, 30327, United States
Site Reference ID/Investigator# 7891
Newnan, Georgia, 30263, United States
Site Reference ID/Investigator# 7932
Snellville, Georgia, 30078, United States
Site Reference ID/Investigator# 8379
Arlington Heights, Illinois, 60005, United States
Site Reference ID/Investigator# 8798
Maywood, Illinois, 60153, United States
Site Reference ID/Investigator# 10703
Schaumburg, Illinois, 60194, United States
Site Reference ID/Investigator# 6950
Skokie, Illinois, 60077, United States
Site Reference ID/Investigator# 7892
West Dundee, Illinois, 60118, United States
Site Reference ID/Investigator# 6933
Indianapolis, Indiana, 46256, United States
Site Reference ID/Investigator# 10422
Indianapolis, Indiana, 46260, United States
Site Reference ID/Investigator# 16581
Plainfield, Indiana, 46168, United States
Site Reference ID/Investigator# 7992
Overland Park, Kansas, 66202, United States
Site Reference ID/Investigator# 17193
Henderson, Kentucky, 42420, United States
Site Reference ID/Investigator# 8528
Louisville, Kentucky, 40202, United States
Site Reference ID/Investigator# 9962
Owensboro, Kentucky, 42303, United States
Site Reference ID/Investigator# 8529
Andover, Massachusetts, 01810, United States
Site Reference ID/Investigator# 8149
Boston, Massachusetts, 02111, United States
Site Reference ID/Investigator# 9823
Detroit, Michigan, 48202, United States
Site Reference ID/Investigator# 7883
Fort Gratiot, Michigan, 48059, United States
Site Reference ID/Investigator# 7238
Grand Blanc, Michigan, 48439, United States
Site Reference ID/Investigator# 7656
Fridley, Minnesota, 55432, United States
Site Reference ID/Investigator# 6930
St Louis, Missouri, 63110, United States
Site Reference ID/Investigator# 6949
St Louis, Missouri, 63117, United States
Site Reference ID/Investigator# 7240
Omaha, Nebraska, 68131, United States
Site Reference ID/Investigator# 9567
Omaha, Nebraska, 68144, United States
Site Reference ID/Investigator# 7757
Berlin, New Jersey, 08009, United States
Site Reference ID/Investigator# 7330
East Windsor, New Jersey, 08520, United States
Site Reference ID/Investigator# 7882
New Brunswick, New Jersey, 08903, United States
Site Reference ID/Investigator# 7455
Albuquerque, New Mexico, 87106, United States
Site Reference ID/Investigator# 8078
Buffalo, New York, 14221, United States
Site Reference ID/Investigator# 8392
New York, New York, 10016, United States
Site Reference ID/Investigator# 8006
New York, New York, 10025, United States
Site Reference ID/Investigator# 7230
New York, New York, 10029-6501, United States
Site Reference ID/Investigator# 10201
New York, New York, 10032, United States
Site Reference ID/Investigator# 8037
Rochester, New York, 14623, United States
Site Reference ID/Investigator# 7333
Stoney Brook, New York, 11790, United States
Site Reference ID/Investigator# 7434
Hickory, North Carolina, 28602, United States
Site Reference ID/Investigator# 8117
Wilmington, North Carolina, 28401, United States
Site Reference ID/Investigator# 9681
Winston-Salem, North Carolina, 27157, United States
Site Reference ID/Investigator# 6945
Cincinnati, Ohio, 45219, United States
Site Reference ID/Investigator# 23345
Cincinnati, Ohio, 45220, United States
Site Reference ID/Investigator# 7044
Cleveland, Ohio, 44106, United States
Site Reference ID/Investigator# 7899
Columbus, Ohio, 43212, United States
Site Reference ID/Investigator# 8389
Dayton, Ohio, 45408, United States
Site Reference ID/Investigator# 11181
Oklahoma City, Oklahoma, 73104, United States
Site Reference ID/Investigator# 6936
Lake Oswego, Oregon, 97035, United States
Site Reference ID/Investigator# 7703
Portland, Oregon, 97210, United States
Site Reference ID/Investigator# 6948
Portland, Oregon, 97223, United States
Site Reference ID/Investigator# 11424
Portland, Oregon, 97239, United States
Site Reference ID/Investigator# 8494
Hershey, Pennsylvania, 17033, United States
Site Reference ID/Investigator# 7930
Philadelphia, Pennsylvania, 19103, United States
Site Reference ID/Investigator# 6934
Johnston, Rhode Island, 02919, United States
Site Reference ID/Investigator# 6935
Providence, Rhode Island, 02903, United States
Site Reference ID/Investigator# 7785
Greer, South Carolina, 29650, United States
Site Reference ID/Investigator# 7497
Goodlettsville, Tennessee, 37072, United States
Site Reference ID/Investigator# 7388
Knoxville, Tennessee, 37934, United States
Site Reference ID/Investigator# 6931
Nashville, Tennessee, 37215, United States
Site Reference ID/Investigator# 7684
Arlington, Texas, 76011, United States
Site Reference ID/Investigator# 10842
Austin, Texas, 78759, United States
Site Reference ID/Investigator# 7498
Dallas, Texas, 75230, United States
Site Reference ID/Investigator# 6947
Dallas, Texas, 75246-1613, United States
Site Reference ID/Investigator# 6944
Houston, Texas, 77030, United States
Site Reference ID/Investigator# 7758
San Antonio, Texas, 78229, United States
Site Reference ID/Investigator# 8108
San Antonio, Texas, 78229, United States
Site Reference ID/Investigator# 6937
Tyler, Texas, 75703, United States
Site Reference ID/Investigator# 7655
Webster, Texas, 77598, United States
Site Reference ID/Investigator# 10207
Salt Lake City, Utah, 84132, United States
Site Reference ID/Investigator# 6946
Norfolk, Virginia, 23507, United States
Site Reference ID/Investigator# 6932
Seattle, Washington, 98101, United States
Site Reference ID/Investigator# 10306
Spokane, Washington, 99204, United States
Site Reference ID/Investigator# 7884
Milwaukee, Wisconsin, 53209, United States
Site Reference ID/Investigator# 16845
Graz, 8036, Austria
Site Reference ID/Investigator# 18183
Vienna, 1090, Austria
Site Reference ID/Investigator# 15761
Brussels, 1200, Belgium
Site Reference ID/Investigator# 7991
Barrie, L4M 6L2, Canada
Site Reference ID/Investigator# 8047
Calgary, T3G 0B4, Canada
Site Reference ID/Investigator# 7996
Edmonton, T5K 1X3, Canada
Site Reference ID/Investigator# 6996
Halifax, B3H 0A2, Canada
Site Reference ID/Investigator# 7236
Hamilton, L8N 1V6, Canada
Site Reference ID/Investigator# 6995
Laval, H7S 2C6, Canada
Site Reference ID/Investigator# 6998
London, N5X 2P1, Canada
Site Reference ID/Investigator# 7043
London, N6A 3H7, Canada
Site Reference ID/Investigator# 7329
Markham, L3P 1A8, Canada
Site Reference ID/Investigator# 6999
Montreal, H2K 4L5, Canada
Site Reference ID/Investigator# 7652
Montreal, H3H 1V4, Canada
Site Reference ID/Investigator# 7006
North Bay, P1B 3Z7, Canada
Site Reference ID/Investigator# 8102
Ottawa, K2G 6E2, Canada
Site Reference ID/Investigator# 6993
Québec, G1V 4X7, Canada
Site Reference ID/Investigator# 8112
St. John's, A1A 5E8, Canada
Site Reference ID/Investigator# 7931
Surrey, V3R 6A7, Canada
Site Reference ID/Investigator# 8118
Vancouver, V5Z 3Y1, Canada
Site Reference ID/Investigator# 6997
Vancouver, V5Z 4E8, Canada
Site Reference ID/Investigator# 6994
Waterloo, N2J 1C4, Canada
Site Reference ID/Investigator# 8111
Westmount, H3Z 2S6, Canada
Site Reference ID/Investigator# 7005
Windsor, N8W 1E6, Canada
Site Reference ID/Investigator# 7979
Windsor, N8W 5L7, Canada
Site Reference ID/Investigator# 8348
Winnipeg, R3C 1R4, Canada
Site Reference ID/Investigator# 17781
Aarhus, 8000, Denmark
Site Reference ID/Investigator# 18041
Copenhagen NV, 2400, Denmark
Site Reference ID/Investigator# 18661
Helsinki, 00029 HUS, Finland
Site Reference ID/Investigator# 18701
Kuopio, 70210, Finland
Site Reference ID/Investigator# 14962
Lahti, 15850, Finland
Site Reference ID/Investigator# 19241
Turku, 20521, Finland
Site Reference ID/Investigator# 18502
Nice, 06200, France
Site Reference ID/Investigator# 16781
Paris, 75475, France
Site Reference ID/Investigator# 18506
Toulouse, 31059, France
Site Reference ID/Investigator# 16281
Berlin, 10117, Germany
Site Reference ID/Investigator# 15664
Frankfurt am Main, 60590, Germany
Site Reference ID/Investigator# 15663
Hamburg, D-20354, Germany
Site Reference ID/Investigator# 16381
Kiel, 24105, Germany
Site Reference ID/Investigator# 16143
Munich, D-80337, Germany
Site Reference ID/Investigator# 16161
Münster, 48149, Germany
Site Reference ID/Investigator# 17676
Tübingen, 72076, Germany
Site Reference ID/Investigator# 16282
Athens, 161 21, Greece
Site Reference ID/Investigator# 15921
Athens, 16121, Greece
Site Reference ID/Investigator# 15922
Thessaloniki, 54643, Greece
Site Reference ID/Investigator# 15401
Modena, 41100, Italy
Site Reference ID/Investigator# 14881
Rome, 00133, Italy
Site Reference ID/Investigator# 19322
Barcelona, 08916, Spain
Site Reference ID/Investigator# 15341
Madrid, 28006, Spain
Site Reference ID/Investigator# 16142
Stockholm, 171 76, Sweden
Site Reference ID/Investigator# 17721
Geneva, 1211, Switzerland
Site Reference ID/Investigator# 16749
Zurich, 8091, Switzerland
Site Reference ID/Investigator# 19045
Aberdeen, AB25 2ZR, United Kingdom
Site Reference ID/Investigator# 15422
Manchester, M6 8HD, United Kingdom
MeSH Terms
Interventions
Study Officials
- STUDY CHAIR
Martin Kaul, MD
AbbVie
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 22, 2008
First Posted
February 29, 2008
Study Start
February 1, 2008
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
January 30, 2013
Record last verified: 2013-01